Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2008
12/03/2008EP1996580A2 Pyrrazole derivatives as sigma receptors antagonists
12/03/2008EP1996567A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/03/2008EP1996564A1 Dibenzyl amine compounds and derivatives
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008EP1996224A1 Mixtures of amylin and insulin
12/03/2008EP1996222A2 Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
12/03/2008EP1996215A2 Metabolic regulators and uses thereof
12/03/2008EP1996212A2 Compounds from an extract of artemisia and methods for treating disorders
12/03/2008EP1560573B1 Use of n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicyclo[2.2.1]hept-1-ylmethanesulfonamide family members in therapy
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1511499B1 Immunomodulatory compounds and methods of use thereof
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof
12/03/2008EP1423388B1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
12/03/2008EP1383787B1 Sapogenin derivatives, their synthesis and use
12/03/2008EP1377540B1 Inhibitors of integrin alpha-v-beta-6
12/03/2008CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators
12/03/2008CN101316840A 1,5-substituted indol-2-yl amide derivatives
12/03/2008CN101316838A 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
12/03/2008CN101316837A Substituted pyrrolones as allosteric modulators of glucokinase
12/03/2008CN101316836A Substituted dihydroisoindolones as allosteric modulators of glucokinase
12/03/2008CN101316827A Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316822A 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316821A Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316625A Neuropeptide-2 receptor-agonists
12/03/2008CN101316603A Processes for obtaining lignan extracts and compositions containing the lignan extracts
12/03/2008CN101316601A Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
12/03/2008CN101316599A Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of NKT cell as active ingredient
12/03/2008CN101316518A Compositions for increasing lean muscle mass and/or reducing fat gain
12/03/2008CN101314621A Squash polysaccharide and preparation method thereof
12/03/2008CN101314591A Novel pyrazoles highly-selective marijuana acceptor-1antagon and/or reversed activation agent
12/03/2008CN101314031A Preparation for improving osteotrophy
12/03/2008CN101314027A Sea backthern lysine particle
12/03/2008CN101314012A Matrimony vine effervescent tablet
12/03/2008CN101314005A Soft capsule of cherry
12/03/2008CN101313983A Compound garlic soft capsule
12/03/2008CN101313968A Pseudo-ginseng dragon's blood preparation
12/03/2008CN101313958A Compound slimming oolong tea effervescent tablet
12/03/2008CN101313957A Capsule for treating retina vein occlusion
12/03/2008CN101313954A Traditional Chinese medicine externally used effervescing agent (tablet) for pedicuring
12/03/2008CN101313950A Compound purslane capsule
12/03/2008CN101313943A Chinese medicinal composition for treating nephropathy and preparation thereof
12/03/2008CN101313942A Chinese medicine composition for treating nephropathy
12/03/2008CN101313941A Compound antihyperglycemic pellet preparation and preparation method thereof
12/03/2008CN101313922A Method for obtaining extract from several frequently seen plants and uses of the extract
12/03/2008CN101313921A Tortoise plastron capsule for for persons in middle and old age
12/03/2008CN101313919A Rice fermented with red yeast extract, preparation method and quality detection method thereof
12/03/2008CN101313900A Hydroxy fatty acid oligomer and application in regulating calcium ion concentration in cell
12/03/2008CN101313897A Application of phaffia rhodozyma astaxanthin in preparing medicament for preventing and controlling type II diabetes
12/03/2008CN101313892A Glipizide calcium alginate gel rubber pellet and preparation method thereof
12/03/2008CN100439920C Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
12/03/2008CN100439399C Human antibodies that bind human IL-12 and methods for producing
12/03/2008CN100439397C Crystallization of IGF-1
12/03/2008CN100439396C Polypeptide of ramification of ciliary nerves nutrilite for curing obesity
12/03/2008CN100439369C Purine compounds and use thereof as cannabinoid receptor ligands
12/03/2008CN100439361C Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/03/2008CN100439357C Benzo [b][1,4] dioxepine derivatives
12/03/2008CN100439347C 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
12/03/2008CN100439346C Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
12/03/2008CN100439345C (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
12/03/2008CN100439342C Polymorphic forms of a known antihyperlipemic agent
12/03/2008CN100439337C Phenyl substituted piperidine compounds for use as PPAR activators
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100438911C Body weight gain inhibitor
12/03/2008CN100438899C Medicine for treating diabetes and its preparing method
12/03/2008CN100438880C Selenium-complement agent, and prepn. method and use thereof
12/03/2008CN100438878C Active largehead atractylodes saccharide complex for reducing blood sugar and its prepn and use
12/03/2008CN100438877C (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
12/03/2008CN100438868C New alpha-glucosidase inhibitors from a natural source
12/03/2008CN100438862C Composition for administration to mucosa and containing coenzyme Q as active ingredient
12/03/2008CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum
12/03/2008CN100438779C Nutritional composition with health promoting action containing oligosaccharides
12/02/2008US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459481 Adust fatty acid oxidation; stimulant of carnitine plamitoyl treansferrase
12/02/2008US7459480 Benzodioxepine derivatives
12/02/2008US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459432 adminsteration of Peptide YY or an agonist to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism
12/02/2008US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety.
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008US7459159 Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia
12/02/2008US7459151 Phosphate-binding polymers for oral administration
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2409771C Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
12/02/2008CA2377668C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2303395C Treatment of obesity
12/02/2008CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them
11/2008
11/30/2008CA2594214A1 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144346A2 Crystal structures of sglt2 inhibitors and processes for their preparation
11/27/2008WO2008143491A1 Pharmaceutical compositions combining a hydrogenated lipstatin derived agent and a hmg-coa reductase inhibiting agent
11/27/2008WO2008143354A1 Pharmaceutical composition for enzyme replacement therapy
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008143182A1 Composition containing licorice-derived polyphenol
11/27/2008WO2008142986A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
11/27/2008WO2008142860A1 Novel sweetener having sugar-like taste and production method and use of the same
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 1298